Knowledge Transfer UNIL-CHUV supports researchers and industry partners in valorising academic innovation.
50+
Patents filled
30+
Start-ups supported
5MCHF
Funded
25years
Of expertise

Our 4 pillars

Safeguard and enhance the value of your innovative inventions to ensure they receive the recognition they deserve.
Engage in collaboration with various industry partners to foster innovation and drive mutual success.
Secure the necessary funding for your start-up or proof of concept to bring your innovative ideas to life.
Receive comprehensive support for all your grant applications, ensuring you have the guidance you need to succeed.

For Researcher

A personalized service to inventors
In collaboration with a professional network, with regards to all aspects of technology evaluation, protection of intellectual property rights and creation of a start-up.

For Industry

Find a collaboration, or invest in a technology
We are the primary contact point to engage in any collaboration, partnership or venture with researchers from the University of Lausanne or the CHUV.

Technologies available for

Licensing

Category: Medical Imaging
Institute: University Hospital of Lausanne
With the increasing realization of the crucial roles played by microbial communities for human, animal, high-throughput methods of microbiota analysis are gaining ever greater importance.
Category: Medical Imaging
Institute: University Hospital of Lausanne
oday’s MRI-based cardiovascular markers rely heavily on either manual segmentation or opaque end-to-end AI prediction tools, which can limit scalability and clinician trust.
Category: Pharmaceuticals
Institute: University of Lausanne
Sexually transmitted infections (STIs) continue to rise globally, highlighting an urgent need for prevention tools that go beyond pathogen-specific antivirals and vaccines.
Category: Pharmaceuticals
Institute: University of Lausanne
CAR-T cells, while promising in immunotherapy as a key strategy for cancer treatment, often become unresponsive, especially in elderly patients or in solid tumors.
Category: Medical Imaging
Institute: University Hospital of Lausanne
The suppression of fat signals is an important component of many magnetic resonance imaging (MRI) exams in the clinic. Signals from fat need to be suppressed to obtain high quality images.
Category: Pharmaceuticals
Institute: University Hospital of Lausanne
Social impairment is frequently associated with mitochondrial dysfunc on and altered neurotransmission. Although mitochondrial func on is crucial for brain homeostasis, this has not yet been exploited to develop therapies for neurodevelopmental disorders.
Category: Medical devices
Institute: University Hospital of Lausanne
Trigger finger or stenosing tenosynovitis is a common medical disorder of the hand. It is characterised by the catching or locking of the involved flexor tendon. When a tendon is inflamed or swollen, it may not fit properly into the tendon sheath that surrounds and supports it.
Category: Pharmaceuticals
Institute: University Hospital of Lausanne
Enhancing Cancer Imaging & Surgery with Multi-Modal Precision
Success

stories

Startup Alpha

Lorem ipsum dolor ....
12M
CHF
Raised, Series A 2023

Startup Alpha

Lorem ipsum dolor ....
12M
CHF
Raised, Series A 2023
Partner for an 
Innovative World
We are the joint the joint technology transfer office of the University of Lausanne (UNIL) and the University Hospital of Lausanne (CHUV).
Here are what we focus on:
Latest

news

Uncategorized
InnoTREK: one-year financial support to create your start-up

You are a UNIL-CHUV researcher who would like to create a start-up and need a financial support to start? Apply for a one-year InnoTREK grant of CHF 100’000.- to launch your project! Applications for the InnoTREK grant can be submitted throughout the year to the Knowledge Transfer UNIL CHUV. Project selection will take place in […]

Uncategorized
BioInnovation Day 2026 : Journée dédiée aux Innovateurs & Investisseurs

  Le BIND BioInnovation Day 2026 aura lieu le 1er avril 2026 au CHUV – Auditoire César Roux. Une trentaine de projets innovants issus des meilleures institutions académiques et de recherche de Suisse occidentale y seront présentés devant le public et les investisseurs. L’événement est organisé par BioAlps en partenariat avec KT UNIL–CHUV et UNITEC. […]

Uncategorized
A Unil Discovery for Vaccine Development Turns into a Start-Up

The CRISPRi-seq technology, stemming from fundamental research within the team of Professor Jan-Willem Veening at the University of Lausanne, has reached a decisive milestone: it has been licensed to the start-up “i-Seq Biotechnology”. This innovation paves the way for new vaccines against diseases for which there is currently no protection. It all started with a […]

Uncategorized
The project Hevelion wins an InnoTREK grant

The Knowledge Transfer UNIL CHUV congratulates Marco Varrone from the University of Lausanne (UNIL), Department of Computational Biology, for obtaining an InnoTREK grant for his start-up project: Hevelion Warmest congratulations also to the other recipients of this grant. Wishing you all every success and the best of luck in the next steps of your project […]

Uncategorized
InnoTREK: one-year financial support to create your start-up

You are a UNIL-CHUV researcher who would like to create a start-up and need a financial support to start? Apply for a one-year InnoTREK grant of CHF 100’000.- to launch your project! Applications for the InnoTREK grant can be submitted throughout the year 2025 to the Knowledge Transfer UNIL CHUV. Project selection will take place […]

Uncategorized
Un jubilé synonyme de renaissance

Article rédigé par Startupticker.ch : Un jubilé synonyme de renaissance

Have a project? Let's talk.
Our team is available to discuss your needs, for free.